Determinants of Repeated Spontaneous Miscarriages and Unexplained Fetal Deaths

Recruiting N/A Interventional Study
Repeated Spontaneous Miscarriages Fetal Deaths in Utero
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 40
Sex
Any
Study type
Interventional
Purpose
Other
Participants needed
200 (estimated)
Sponsor
University Hospital, Brest · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The DEFI-1 study recruited 625 women witnesses and 299 of their spouses. With regard to case couples, 271 cases were recruited from the spontaneous repeated miscarriages (SRM) subgroup (≥3 spontaneous miscarriage (SM) from trimester 1 of pregnancy) and 93 from the unexplained fetal death in utero (FDIU) subgroup from trimesters 2 and 3 of pregnancy. The main objective of the DEFI 2 study is to in…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * couples whose wife is over 18 and under 40 inclusive, * couples having undergone at least 3 unexplained SM in the first trimester or an FDIU in the trimesters 2 and 3 of pregnancy (excluding funicular and fetal causes and proven preeclampsia) * the man must be over 18 years ol…
Contacts

Elisabeth Pasquier, MD

0298145013

elisabeth.pasquier@chu-brest.fr

CONTACT